Purpose of the development: Nanosilica "Dance" is intended for the production of highly filled polymers, including medical purposes, in particular in dentistry.

Recommended application field: Dentistry, pharmacology,chemistry.

Advantages over analogues: Unlike silica Asil 300 is characterized by low-gelling ability, so it can be used for creating highly filled (50-60 wt.%) Of polymer systems. Asil silica-300 can be incorporated into the composition is not more than 10% by weight. Unlike the drug "Siliks" on the basis of pharmaceutical Silica Asil-300, "Dance-Pharma" is characterized by a low osmotic activity and absorbs water while maintaining acceptable properties of the design.

The development stage readiness: Ready for application

Description of the development:
()
"Dance" is a white powder with finely divided nanoscale bulk density of 300-400 g / l, obtained by machining with a ball mill pyrogenic silica Asil-300. On the basis of the material "Dance" developed "Dance-Pharma" - amorphous nanoscale silica of high purity, intended for the manufacture of pharmaceutical products. Previous studies have shown its high efficiency as a sorbent applicator for the treatment of purulent wounds on the first and second stages of the wound healing process. specifications have already been developed and the temporary technological regulations for the production of highly silica geometrically modified "Dance". Also got the conclusion of the state sanitary-epidemiological expertise.

corresponds technical description
Ready for implementation

Possibility of transfer abroad:
Licence's sale
Combinated reduction to industrial level

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua